Natural Biogenex Private Limited ("Material Unlisted Subsidiary"), at its Board Meeting held on today, i.e. July 31, 2026, has approved the Allotment of the Right Issue duly approved on ....

A C C R E D I T E D ISO/IEC 17021 CERTIFICATION BODY Date: July 31, 2026 To To BSE Limited National Stock Exchange of India Limited 25th Floor, PJ Towers Exchange Plaza, C-1, Block G Dalal Street, Bandra Kurla Complex, Bandra (E) Mumbai – 400001 Mumbai – 400051 Scrip Code: 524654 Symbol: NATCAPSUQ Sub: Intimation under Regulation 30(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, This is to inform you that under Regulation 30(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; Natural Biogenex Private Limited (“Material Unlisted Subsidiary”), at its Board Meeting held on today, i.e. July 31, 2026 has approved the Allotment of the Right Issue duly approved on Board Meeting dated on July 10, 2026 of the Company. Approval is received to make the allotment of 9,46,305 Equity Shares of face value of ₹10/- each for cash at par, aggregating to ₹ 94,63,050/- (Rupees Ninety Four Lakh Sixty-Three Thousand and Fifty only). Kindly take the aforesaid intimation on record. Thanking You Yours Faithfully, For Natural Capsules Limited Akshay Dutta Company Secretary and Compliance Officer M.No. A80481